PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients

Abstract PAM50 intrinsic subtyping and risk of recurrence (ROR) score are approved for risk profiling in postmenopausal women. We aimed to examine their long-term prognostic value in terms of breast cancer-free interval (BCFi) and overall survival (OS) (n = 437) in premenopausal women randomised to...

Full description

Bibliographic Details
Main Authors: Christine Lundgren, Pär-Ola Bendahl, Sarah E. Church, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-022-00423-z